Literature DB >> 7780313

New tuberculosis epidemic. Controversies in screening and preventive therapy.

J S Remington1, G R Hollingworth.   

Abstract

The incidence of tuberculosis is increasing in many regions of Canada and the world. Accurate and current knowledge of screening and prevention is of utmost importance for family physicians caring for patients who might be at risk. This article presents guidelines on screening, skin testing, interpretation of results, and preventive therapy.

Entities:  

Mesh:

Year:  1995        PMID: 7780313      PMCID: PMC2146573     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  18 in total

1.  The booster phenomenon in serial tuberculin testing.

Authors:  N J Thompson; J L Glassroth; D E Snider; L S Farer
Journal:  Am Rev Respir Dis       Date:  1979-04

2.  Editorial: Measurement of delayed skin-test responses.

Authors:  J E Sokal
Journal:  N Engl J Med       Date:  1975-09-04       Impact factor: 91.245

3.  Tuberculin sensitivity in pregnancy.

Authors:  P A Present; G W Comstock
Journal:  Am Rev Respir Dis       Date:  1975-09

Review 4.  Resurgence of tuberculosis in children.

Authors:  J R Starke; R F Jacobs; J Jereb
Journal:  J Pediatr       Date:  1992-06       Impact factor: 4.406

Review 5.  Isoniazid-associated hepatitis deaths: a review of available information.

Authors:  D E Snider; G J Caras
Journal:  Am Rev Respir Dis       Date:  1992-02

6.  Prevention of tuberculosis among tuberculin reactors: maximizing benefits, minimizing risks.

Authors:  G W Comstock
Journal:  JAMA       Date:  1986-11-21       Impact factor: 56.272

7.  Effect of bacille Calmette-Guérin vaccination on tuberculin reactivity.

Authors:  R Menzies; B Vissandjee
Journal:  Am Rev Respir Dis       Date:  1992-03

8.  Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers.

Authors:  M L Pearson; J A Jereb; T R Frieden; J T Crawford; B J Davis; S W Dooley; W R Jarvis
Journal:  Ann Intern Med       Date:  1992-08-01       Impact factor: 25.391

9.  The age threshold for isoniazid chemoprophylaxis. A decision analysis for low-risk tuberculin reactors.

Authors:  D N Rose; C B Schechter; A L Silver
Journal:  JAMA       Date:  1986-11-21       Impact factor: 56.272

10.  Factors associated with tuberculin reactivity among the foreign-born in Montreal.

Authors:  R Menzies; B Vissandjee; D Amyot
Journal:  Am Rev Respir Dis       Date:  1992-09
View more
  4 in total

Review 1.  Mantoux (tuberculosis) testing. Evaluation of guidelines for testing in Canadian institutions.

Authors:  R E Thomas
Journal:  Can Fam Physician       Date:  1997-05       Impact factor: 3.275

2.  How much does it cost to manage paediatric tuberculosis? One-year experience from The Hospital for Sick Children.

Authors:  C L Main; E Ying; E E Wang
Journal:  Can J Infect Dis       Date:  1998-11

3.  Tuberculosis. A widespread health issue.

Authors:  D Holton
Journal:  Can Fam Physician       Date:  1995-09       Impact factor: 3.275

4.  [Prevalence of positive tuberculin test in a population of patients requiring long-term care in a hospital setting].

Authors:  Y Leduc; S Drapeau; I Samson; R Tremblay; J G Emond
Journal:  Can Fam Physician       Date:  1997-12       Impact factor: 3.275

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.